News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Third Rock Ventures II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0% stake in Allena Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0.6% stake in Jounce Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 8.1% stake in Jounce Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 2.2% stake in Sage Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 6% stake in Blueprint Medicines Corporation |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0.7% stake in Global Blood Therapeutics, Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Global Blood Therapeutics, Inc. reports a 24% stake in Global Blood Therapeutics, Inc. |
| 02/13/2017 |
SC 13G/A
| MyoKardia Inc reports a 32.1% stake in MYOKARDIA, INC. |
|
|